Who
Aaron G.L. Fletcher
Director and 10% owner
Company insider
Files Form 4 as: Director and 10% owner, Cognition Therapeutics; Director and 10% owner, Actuate Therapeutics; 10% owner, Lantern Pharma; Director, Cue Biopharma; Director, TFF Pharmaceuticals; Director, SWK Holdings.
In numbers
- Trades disclosed
- 99
- Buys
- 17
- Sells
- 4
- Bought
- $11.2M
- Sold
- $690K
- Companies
- 6
- Companies where not an officer
- 6
- First trade
- 30 Sep 2019
- Last trade
- 17 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 22 Jun 2026 | CGTX Cognition TherapeuticsBiotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | ACTU Actuate Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | ACTU Actuate Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 19 Sep 2025filed 23 Sep 2025 | CGTX Cognition Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,729 at $0.00 | filing |
| 19 Sep 2025filed 23 Sep 2025 | CGTX Cognition TherapeuticsBiotechnology | SEC FORM 4 Code M | $6,4927,729 at $0.84 | filing |
| 22 May 2025filed 23 May 2025 | ACTU Actuate Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 24 May 2024filed 28 May 2024 | LTRN Lantern PharmaBiotechnology | SEC FORM 4 Sold | $12K1,859 at $6.33 | filing |
| 24 May 2024filed 28 May 2024 | LTRN Lantern PharmaBiotechnology | SEC FORM 4 Sold | $88K13,888 at $6.33 | filing |
| 24 May 2024filed 28 May 2024 | LTRN Lantern PharmaBiotechnology | SEC FORM 4 Sold | $27K4,253 at $6.33 | filing |
| 23 May 2024filed 28 May 2024 | LTRN Lantern PharmaBiotechnology | SEC FORM 4 Sold | $5,813930 at $6.25 | filing |
| 23 May 2024filed 28 May 2024 | LTRN Lantern PharmaBiotechnology | SEC FORM 4 Sold | $43K6,944 at $6.25 | filing |
| 23 May 2024filed 28 May 2024 | LTRN Lantern PharmaBiotechnology | SEC FORM 4 Sold | $13K2,126 at $6.25 | filing |
| 29 Nov 2023filed 1 Dec 2023 | LTRN Lantern PharmaBiotechnology | SEC FORM 4 Sold | $185K53,640 at $3.44 | filing |
| 29 Nov 2023filed 1 Dec 2023 | LTRN Lantern PharmaBiotechnology | SEC FORM 4 Sold | $315K91,708 at $3.44 | filing |
| 8 Nov 2023filed 13 Nov 2023 | CGTX Cognition TherapeuticsBiotechnology | SEC FORM 4 Code A | $525K500,095 at $1.05 | filing |
| 3 Jan 2023filed 5 Jan 2023 | CUE Cue Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 29 Dec 2022filed 30 Dec 2022 | TFF Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —33,475 at $0.00 | filing |
| 22 Nov 2022filed 23 Nov 2022 | TFF Pharmaceuticalsoption or derivative | SEC FORM 4 Code P | —21,735 at $0.00 | filing |
| 22 Nov 2022filed 23 Nov 2022 | TFF Pharmaceuticals | SEC FORM 4 Bought | $50K43,470 at $1.15 | filing |
| 10 Jun 2022filed 14 Jun 2022 | CGTX Cognition Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code J | —8,335 at $0.00 | filing |
News
Cue Biopharma (NASDAQ:CUE) Stock: Insider Michael Vincent Meluzio Sells 1,144 SharesCUE · dailypolitical.com · 15 Oct 2026Cue Biopharma (NASDAQ:CUE) Insider Sells $51,724.20 in StockCUE · themarketsdaily.com · 15 Oct 2026Cognition Therapeutics (NASDAQ:CGTX) Stock Falls 2% – Here's WhyCGTX · dailypolitical.com · 10 Oct 2026Lantern Pharma (NASDAQ:LTRN) Stock Price Up 1.4% – Here's What HappenedLTRN · tickerreport.com · 8 Oct 2026Contrasting Cue Biopharma (NASDAQ:CUE) & REGENXBIO (NASDAQ:RGNX)CUE · dailypolitical.com · 8 Oct 2026
0 headlines in the last 90 days name Aaron G.L. Fletcher; 5 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.